Curaleaf Holdings Files 6-K, Opts for Form 40-F

Ticker: CURLF · Form: 6-K · Filed: 2024-05-17T00:00:00.000Z

Sentiment: neutral

Topics: reporting, sec-filing, legal

Related Tickers: CURLF

TL;DR

Curaleaf filed a 6-K, confirming they'll use Form 40-F for annual reports.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on May 17, 2024, reporting for the month of May 2024. The filing indicates that Curaleaf will file its annual reports under Form 40-F, not Form 20-F. The report was signed by Peter Clateman, Chief Legal Officer, on May 16, 2024.

Why It Matters

This filing clarifies Curaleaf's reporting obligations with the SEC, indicating their choice of Form 40-F for annual reports, which is common for Canadian companies.

Risk Assessment

Risk Level: low — This is a routine administrative filing that does not contain new financial or operational information.

Key Players & Entities

Curaleaf Holdings, Inc. (company) — Registrant
Peter Clateman (person) — Chief Legal Officer
May 16, 2024 (date) — Date of signature
May 17, 2024 (date) — Filing date
Form 40-F (document) — Annual report form
Form 20-F (document) — Alternative annual report form

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report information that Curaleaf Holdings, Inc. has made or is required to make public in Canada or has filed or is required to file with the SEC, and to indicate the form under which it will file its annual reports.

Which form will Curaleaf Holdings, Inc. use for its annual reports?

Curaleaf Holdings, Inc. will file its annual reports under cover of Form 40-F.

Who signed this Form 6-K filing on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed the Form 6-K filing on behalf of Curaleaf Holdings, Inc.

On what date was this Form 6-K filed with the SEC?

This Form 6-K was filed with the SEC on May 17, 2024.

What is Curaleaf's principal executive office address?

Curaleaf's principal executive office is located at 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada.

From the Filing

0001756770-24-000039.txt : 20240517 0001756770-24-000039.hdr.sgml : 20240517 20240516200848 ACCESSION NUMBER: 0001756770-24-000039 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 21 CONFORMED PERIOD OF REPORT: 20240516 FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 24957413 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover051624.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: May 16, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Management Information Circular 99.2 Notice of Meeting 99.3 Form of Proxy 99.4 Voting Instruction Form EX-99.1 2 managementinformationcircu.htm EX-99.1 Document CURALEAF HOLDINGS, INC. NOTICE OF ANNUAL GENERAL MEETING OF THE SHAREHOLDERS TO BE HELD ON JUNE 14, 2024 AND MANAGEMENT INFORMATION CIRCULAR May 6, 2024 118519292 CURALEAF HOLDINGS, INC. NOTICE OF ANNUAL GENERAL MEETING OF THE SHAREHOLDERS AND NOTICE OF AVAILABILITY OF MEETING MATERIALS NOTICE IS HEREBY GIVEN that the annual general meeting of the shareholders (the “ Meeting ”) of Curaleaf Holdings, Inc. (the “ Company ”) will be held on June 14, 2024 at 9:00 a.m. (Eastern Time). This year again, the meeting will be held in a virtual format only. Our virtual annual general meeting of shareholders will allow all shareholders an equal opportunity to attend, vote and submit questions, no matter where they may physically be located on June 14, 2024. The Meeting will be held in virtual form only via live webcast at https://web.lumiconnect.com/268315222. The items for consideration at the Meeting are as follows: 1. to receive and consider the annual audited financial statements of the Company for the financial year ended December 31, 2023, together with the notes thereto and the auditors’ report thereon (the “ Financial Statements ”); 2. set the number of directors to ten (10) and elect as directors for the forthcoming year the nominees proposed by the Company (see page 3 of the accompanying management information circular (the “ Information Circular ”)); 3. to re-appoint PKF O’Connor Davies, LLP (“ PKF O’Connor Davies ”), Chartered Professional Accountants as auditors of the Company and authorize the board of directors of the Company (the “ Board ”) to fix the auditors’ remuneration and terms of engagement (see page 8 of the Information Circular); and 4. to transact such